Studies of obinutuzumab, a type II anti-CD20 antibody, have shown efficacy in the treatment of hematologic cancers and autoimmune diseases. An evaluation of the efficacy and safety of obinutuzumab in ...
When you're ready to start your first chat, click or tap New chat, type your prompt in the composer, and press Enter or tap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results